Treatable

Polymyxin B

Polymyxin-class Antibacterial

Polymyxin B injectable solution

Polymyxin B irrigation solution

Polymyxin B side effects

Adverse Event ReportedReporting Odds RatioCase Count
Pterygium239.303485
Engraftment syndrome93.851177
Engraft failure86.433365
Graft versus host disease in intestine72.679195
Graft versus host disease in skin71.411477
Chronic graft versus host disease48.374816
Acute graft versus host disease in skin40.1710613
Cytomegalovirus test positive39.431679
Otitis externa30.560316
Acute graft versus host disease in intestine27.035385
Mucous membrane disorder24.345936
Acute graft versus host disease22.4793612
Venoocclusive liver disease19.485397
Cytomegalovirus viraemia18.893665
Thrombotic microangiopathy18.026469
Leukoencephalopathy16.951046
Graft versus host disease13.8121211
Hypoalbuminaemia12.9426811
Disseminated intravascular coagulation12.8106924
Enterococcal infection11.730677
Hepatic function abnormal10.6654830
Staphylococcal sepsis10.636598
Neutrophil count decreased6.8643317
Febrile neutropenia6.3105235
Cytomegalovirus infection6.191498
Stomatitis6.1235320
Blood albumin decreased5.781397
Acute respiratory distress syndrome5.6536210
Skin exfoliation5.5266913
C-reactive protein increased5.3386714

Polymyxin B desired effects:

  • Cellular Structure Alteration

Polymyxin B contraindicated conditions:

Polymyxin B drug classes:

  • Polymyxin-class Antibacterial

Polymyxin B pharmacologic actions:

  • Anti-Infective Agents, Local
  • Anti-Bacterial Agents

Polymyxin B mechanism of action:

  • Acid-Base Activity
  • treatable

Copyright © Treatable 2021
Last updated: 7/22/2021, 7:52:12 AM